1. Home
  2. Labeler Index
  3. Noon Aesthetics M.r. Ltd
  4. NDC Product Code: 78863-2700 Noon Cartessa Accelerate Program

NDC 78863-2700 Noon Cartessa Accelerate Program

Allantoin,Titanium Dioxide,Octocrylene,And Avobenzone Kit - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 78863-2700?
  4. Noon Cartessa Accelerate Program Uses
  5. Active Ingredients UNII Codes
  6. Inactive Ingredients UNII Codes
  7. NDC to RxNorm Crosswalk

Product Information

NDC Product Code:
78863-2700
Proprietary Name:
Noon Cartessa Accelerate Program
Non-Proprietary Name: [1]
Allantoin, Titanium Dioxide, Octocrylene, And Avobenzone
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Kit - A packaged collection of related material.
Labeler Name: [5]
Noon Aesthetics M.r. Ltd
Labeler Code:
78863
Product Label ID:
400ead81-ab07-400f-b261-db330e0fd004
FDA Application Number: [6]
M016
Marketing Category: [8]
OTC MONOGRAPH DRUG -
Start Marketing Date: [9]
10-01-2023
Listing Expiration Date: [11]
12-31-2024
Exclude Flag: [12]
N
Code Navigator:

Code Structure Chart

Product Details

What is NDC 78863-2700?

The NDC code 78863-2700 is assigned by the FDA to the product Noon Cartessa Accelerate Program which is a human over the counter drug product labeled by Noon Aesthetics M.r. Ltd. The generic name of Noon Cartessa Accelerate Program is allantoin, titanium dioxide, octocrylene, and avobenzone. The product's dosage form is kit. The product is distributed in a single package with assigned NDC code 78863-2700-1 1 kit in 1 carton * 15 ml in 1 bottle * 15 ml in 1 bottle (78863-1270-2) * 15 ml in 1 bottle * 15 ml in 1 bottle (78863-1230-2) * 15 ml in 1 bottle * 15 ml in 1 bottle. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Noon Cartessa Accelerate Program?

Apply as needed. Apply liberally 15 minutes before sun exposure and as needed.Use a water-resistant sunscreen if swimming or sweating.Reapply at least every 2 hours.Children under 6 months: Ask a doctor.Sun Protection Measures.Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad- spectrum SPF value of 15 or higher and other sun protection measures including:limit time in the sun, especially from 10 a.m.-2 p.m.wear long-sleeved shirts, pants, hats, and sunglasses.

Which are Noon Cartessa Accelerate Program UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Noon Cartessa Accelerate Program Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Noon Cartessa Accelerate Program?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

* Please review the disclaimer below.

Product Footnotes

[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".